C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro.

Name: C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro.
Author: Nikitin, Pavel A

C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro. — المؤلف: Nikitin, Pavel A — Journal of immunology (Baltimore, Md. : 1950) 20191024

المؤلف: Nikitin, Pavel A
النشر: Journal of immunology (Baltimore, Md. : 1950) 20191024
الوصف: 1200-1209 p.
الموضوعات: Antibodies, Monoclonal, Humanized؛ Arthritis, Rheumatoid؛ B-Lymphocytes؛ Cell Proliferation؛ Complement Activation؛ Complement C1s؛ Humans